Free Trial

Graham Doyle Analyst Performance

Analyst at UBS Group

Graham Doyle is a stock analyst at UBS Group, covering 4 publicly traded companies across a range of sectors. Over the past year, Graham Doyle has issued 4 stock ratings, including buy, hold, and sell recommendations. While full access to Graham Doyle's proprietary MarketBeat Analyst Rating is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Graham Doyle's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ratings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
4 Last 0 Years
Buy Recommendations
25.00% 1 Buy Ratings
Companies Covered
4 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy25.0%1 ratings
Hold50.0%2 ratings
Sell25.0%1 ratings

Out of 4 total stock ratings issued by Graham Doyle at UBS Group, the majority (50.0%) have been Hold recommendations, followed by 25.0% Buy and 25.0% Sell.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NYSE
75.0% of companies on NYSE
3 companies
NASDAQ
25.0% of companies on NASDAQ
1 company

Graham Doyle, an analyst at UBS Group, currently covers 4 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.

Coverage Focus

Sector IconSectorPercentage
Medical
4 companies
100.0%

Graham Doyle of UBS Group specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MED PRODUCTS
3 companies
75.0%
MED INSTRUMENTS
1 company
25.0%

Graham Doyle's Ratings History at UBS Group

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
9/2/2025Reiterated Rating$25.71Sell
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
5/5/2025Upgrade$70.53$73.00Neutral
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
3/12/2025Downgrade$29.87Neutral
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
2/20/2025Upgrade$25.06Buy